학술논문
Results of a phase II clinical trial of 6-mercaptopurine (6MP) and methotrexate in patients with BRCA-defective tumours.
Document Type
Journal Article
Author
Source
Subject
*THERAPEUTIC use of antineoplastic agents
*PROTEINS
*RESEARCH
*OVARIAN tumors
*RESEARCH methodology
*CANCER relapse
*EVALUATION research
*MEDICAL cooperation
*METHOTREXATE
*COMPARATIVE studies
*RESEARCH funding
*SALVAGE therapy
*BREAST tumors
*DRUG resistance in cancer cells
*
*
*
*
*
*
*
*
*
*
*
*
*
Language
ISSN
0007-0920
Abstract